Woodline Partners LP - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 84 filers reported holding AMRYT PHARMA PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q4 2022$2,091,764
+5.0%
286,543
-0.5%
0.03%0.0%
Q3 2022$1,993,000
-12.6%
287,982
-11.7%
0.03%
-20.0%
Q2 2022$2,281,000
-42.6%
326,312
-32.1%
0.04%
-45.3%
Q1 2022$3,973,000
+177.8%
480,363
+262.7%
0.06%
+220.0%
Q4 2021$1,430,000132,4380.02%
Other shareholders
AMRYT PHARMA PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$64,658,05627.18%
Stonepine Capital Management, LLC 6,333,239$46,232,64519.45%
MPM ASSET MANAGEMENT LLC 2,668,843$19,482,5548.15%
Aquilo Capital Management, LLC 2,098,993$15,322,6495.76%
New Leaf Venture Partners, L.L.C. 449,737$3,283,0802.38%
Global Frontier Investments LLC 505,000$3,6871.62%
Telemetry Investments, L.L.C. 130,262$9511.50%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$46,2351.27%
Rubric Capital Management LP 3,600,000$26,280,0001.15%
Clearline Capital LP 631,942$4,613,1760.82%
View complete list of AMRYT PHARMA PLC shareholders